Agreed. Abit of a roll up model with true synergies. 21m cap. Take out the acquisition costs and this is a no brainer.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025